Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach

• Autori principali: Paola Orlandi (Autore), Anna Solini (Autore), Marta Banchi (Autore), Maurizia Rossana Brunetto (Autore), Dania Cioni (Autore), Lorenzo Ghiadoni (Autore), Guido Bocci (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2021-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Non-alcoholic fatty liver disease is the most common liver disorder worldwide, and its progressive form non-alcoholic steatohepatitis (NASH) is a growing cause of liver cirrhosis and hepatocellular carcinoma (HCC). Lifestyle changes, which are capable of improving the prognosis, are hard to achieve,...